The prognostic and predictive impact of inflammatory biomarkers in patients who have advanced-stage cancer treated with immunotherapy

导出原文传递

翻译打印收藏纠错

作者： Bilen, Mehmet A. ^[1] ; Martini, Dylan J. ^[2] ; Liu, Yuan ^[3] ; Lewis, Colleen ^[4] ; Collins, Hannah H. ; Shabto, Julie M. ; Akce, Mehmet ; Kissick, Haydn T. ; Carthon, Bradley C. ; Shaib, Walid L. ; Alese, Olatunji B. ; Pillai, Rathi N. ; Steuer, Conor E. ; Wu, Christina S. ; Lawson, David H. ; Kudchadkar, Ragini R. ; El-Rayes, Bassel F. ; Master, Viraj A. ; Ramalingam, Suresh S. ; Owonikoko, Taofeek K. ; Harvey, R. Donald

作者单位： Emory Univ, Sch Med, Dept Urol, Atlanta, GA USA ^[1] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA USA ^[2] Emory Univ, Dept Biostat, Atlanta, GA 30322 USA ^[3] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA ^[4]

关键词 biomarkers clinical outcomes immunotherapy inflammation phase 1 clinical trials

发布时间 2019-09-17

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交